Search by Drug Name or NDC

    NDC 70710-1901-03 Sitagliptin 100 mg/1 Details

    Sitagliptin 100 mg/1

    Sitagliptin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is SITAGLIPTIN.

    Product Information

    NDC 70710-1901
    Product ID 70710-1901_e6912c3b-b985-4107-8093-82654bc1a3bb
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Sitagliptin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Sitagliptin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 100
    Active Ingredient Units mg/1
    Substance Name SITAGLIPTIN
    Labeler Name Zydus Pharmaceuticals (USA) Inc.
    Pharmaceutical Class Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA211566
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1901-03 (70710190103)

    NDC Package Code 70710-1901-3
    Billing NDC 70710190103
    Package 30 TABLET in 1 BOTTLE (70710-1901-3)
    Marketing Start Date 2023-11-30
    NDC Exclude Flag N
    Pricing Information N/A